Abstract
Chagas disease and AIDS: the same terminology cannot be used to associate, let alone confuse, these two diseases with one another without distorting reality, as was done in a recent medical article entitled: “Chagas disease: The New HIV/AIDS of the Americas”. Even though Chagas disease, like many other “neglected diseases”, bears some superficial resemblance to AIDS in certain ways, it nevertheless differs from the latter in many other significant ones.
Résumé
Maladie de Chagas et sida ne sauraient être associés, voire confondus sous un même vocable sans distordre la réalité, comme cela a été fait dans un article médical récent intitulé: Chagas disease: « The New HIV/AIDS of the Americas ». Si la maladie de Chagas, comme bien d’autres « maladies négligées », présente sur certains points, et en apparence seulement, quelques ressemblances avec le sida, elle s’en différencie sur de nombreux autres qui sont essentiels.
Article PDF
References
Apt W (2010) Current and developing therapeutics agents in the treatment of Chagas disease. Drug Des Dev Ther 4:243–253
Aufderheide AC, Salo W, Madden M, et al (2004) A 9000-year record of Chagas’ disease. Proc Natl Acad Sci USA 101(7):2034–2039. Epub 2004 Feb 6
Belge Info (2012) La maladie de Chagas est le nouveau sida des Amériques [www.belgeinfo.com/index.php/328]
Bern C, Montgomery SP, Herwaldt BL, et al (2007) Evaluation and treatment of Chagas disease in the United States: a systematic review. JAMA 298(18):2171–2181
Browne SK, Burbelo PD, Chetchotisakd P, et al (2012) Adultonset immunodeficiency in Thailand and Taiwan. N Eng J Med 367(8):725–734
Brutus L, Santalla JA, Salas NA, et al (2009) Le dépistage de l’infection congénitale par Trypanosoma cruzi en France métropolitaine. Bull Soc Pathol Exot 102(5): 300–310 [http://www.pathexo.fr/documents/articles-bull/T102-5-300-309.pdf]
Chagas C (1909) Nouvelle espèce de trypanosomiase humaine. Bull Soc Pathol Exot 2(6):304–307 [http://www.pathexo.fr/documents/articles-bull/T2-6-304.pdf]
Coura JR (2006) Transmissao da infeçao chagasica por via oral na historia natural da doença de Chagas. Rev Soc Bras Med Trop 39(SIII):113–117
de Andrade AL, Zicker F, de Oliveira RM, et al (1996) Randomised trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. Lancet 348(9039):1407–1413
Dias JC, Silveira AC, Schofield CJ (2002) The impact of Chagas disease control in Latin America: a review. Mem Inst Oswaldo Cruz 97(5):603–612
Fuentes RB, Maturana AM, de la Cruz MR (2012) Eficacia de nifurtimox para el tratamiento de pacientes con enfermedad de Chagas cronica. Rev Chilena Infectol 29(1):82–86. Epub 2012 Apr 10
Guariento ME, Camilo MV, Camargo AM (1999) Working conditions of Chagas’ disease patients in a large Brazilian city. Cad Saude Publica 15(2):381–386
Guedes PM, Silva GK, Gutierrez FR, Silva JS (2011) Current status of Chagas disease chemotherapy. Expert Rev Anti Infect Ther 9(5):609–620
Hashimoto K, Schofield CJ (2012) Elimination of Rhodnius prolixus in Central America. Parasit Vectors 5:45
Hotez PJ, Dumonteil E, Woc-Colburn L, et al (2012) Chagas disease: ”The New HIV/AIDS of the Americas“. PLoS Negl Trop Dis 66(5):e1498. Epub 2012 May 29.
Jackson Y, Angheben A, Carrilero F, et al (2009) Prise en charge de la maladie de Chagas en Europe. Expériences et défis en Espagne, Suisse et Italie. Bull Soc Pathol Exot 102(5)326–29 [http://www.pathexo.fr/documents/articles-bull/T102-5-326-329.pdf]
Jannin J, Simarro PP, Louis FJ (2003) Le concept de maladie négligée. Med Trop 63(3):219–221
Laboratorio E (2012) Abarax contra la enfermedad olvidada [www.elea.com/abarax.php]
Lescure FX, Paris L, Elghouzzi MH, et al (2009) Expérience de dépistage ciblé de la maladie de Chagas en Île-de-France. Bull Soc Pathol Exot 102(5):295–299 [http://www.pathexo.fr/documents/articles-bull/T102-5-295-299.pdf]
Matta Guedes PM, Gutierrez FR, Nascimento MS (2012) Antiparasitical chemotherapy in Chagas’ disease cardiomyopathy: current evidence. Trop Med Int Health 17(9):1057–1065. Epub 2012 Jun 12
Médecins sans frontières, Access Campaign (2011) Treatment Ends for Chagas Patients [www.msfaccess.org/about-us/mediaroom/press-releases/treatment-ends-chagas-patients]
Médecins sans frontières, Access Campaign (2012) Argentina joins Brazil in producing life-saving drug for neglected disease [www.msfaccess.org/about-us/media-room/press-releases/argentina-joins-brazil-producing-life-saving-drug-neglected]
Médecins sans frontières, Access Campaign (2012) Critical shortage of first-line therapy for Chagas: The story of benznidazole [www.msfaccess.org/content/critical-shortage-first-line-therapychagas-story-benznidazole]
Pan America Health Organization (2012) INCOSUR-Chagas: Southern Cone Initiative to Control/Eliminate Chagas Disease [www.paho.org/english/ad/dpc/cd/incosur.htm]
Pays JF (2009) Chagas Carlos Justiniano Ribeiro (1879–1934). Bull Soc Pathol Exot 102(5):276–279 [http://www.pathexo.fr/documents/articles-bull/T102-5-276-279.pdf]
Pays JF (2009). Entre épée de Damoclès et roulette russe• ce que tout le monde sait ou devrait savoir sur la maladie de Chagas. Bull Soc Pathol Exot 102(5):280–284 [http://www.pathexo.fr/documents/articles-bull/T102-5-280-284.pdf]
Pérez-Molina JA, Pérez-Ayala A, Moreno S, et al (2009) Use of benznidazole to treat chronic Chagas’ disease: a systematic review with a meta-analysis. J Antimicrob Chemother 64(6):1139–1147. Epub 2009 Oct 9
Ponce C (2007) Current situation of Chagas disease in Central America. Mem Inst Oswaldo Cruz 102Suppl 1:41–44. Epub 2007 Nov 5.
Ruiz JA, Karunakara U (2006) Chagas Disease Update on progress and future perspectives. Médecins sans frontières, Access campaign [www.ebookbrowse.com/negdis-report-chagas-updateonprogress-eng-2006-pdf-d247372018]
Schmunis GA, Yadon ZE (2010) Chagas disease: a Latin American health problem becoming a world health problem. Acta Trop 115(1–2):14–21. Epub 2009 Nov 20.
Schofield CJ, Dias JC (1991) A cost-benefit analysis of Chagas disease control. Mem Inst Oswaldo Cruz 86(3):285–295
Sosa Estani S, Segura EL, Ruiz AM, et al (1998) Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas’ disease. Am J Trop Med Hyg 59(4):526–529
Toso MA, Vial UF, Galanti N (2011) Transmisión de la enfermedad de Chagas por vía oral. Rev Med Chil 139(2)258–266. Epub 2011 Jul 11
Van de Perre P, Rubbo PA, Viljoen J, et al (2012) HIV-1 reservoirs in breast milk and challenges to elimination of breastfeeding transmission of HIV-1. Sci Transl Med 4(143):143sr3
Viotti R, Vigliano C, Lococo B, et al (2006) Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial. Ann Intern Med 144(10):724–734
Worobey M, Gemmel M, Teuwen DE, et al (2008) Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960. Nature 455(7213):661–664
Yamagata Y, Nakagawa J (2006) Control of Chagas disease. Adv Parasitol 61:129–165
Yun O, Lima MA, Ellman T, et al (2009) Feasibility, drug safety, and effectiveness of etiological treatment programs for Chagas disease in Honduras, Guatemala, and Bolivia: 10-year experience of Médecins Sans Frontières. PLoS Negl Trop Dis 3(7):e488
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Pays, J.F. No, Chagas disease is not the new AIDS of the Americas!. Bull. Soc. Pathol. Exot. 105, 343–348 (2012). https://doi.org/10.1007/s13149-012-0267-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13149-012-0267-4
Keywords
- Chagas disease
- Trypanosomiasis
- Trypanosoma cruzi
- Latin America
- HIV
- AIDS
- Immigrants
- Stigmatization
- Discrimination
- Congenital transmission
- Nifurtimox
- Benznidazole
- Tranfusional risk
- Breastfeeding
- Abarax®